Glial acidic fibrillary protein (GFAP) staining was present throughout the MTL in both NDC and AD subjects, with GFAP-positive cells presenting a stellate morphology representative of activated glia which was different to the morphology of cells expressing NNMT (panels i and j). This evidence concerns the gene GFAP and Alzheimer disease.